AI-PROGNOSIS
banner
aiprognosis.bsky.social
AI-PROGNOSIS
@aiprognosis.bsky.social
AI-PROGNOSIS - a Horizon Europe-funded project developing Artificial intelligence-based solution for Parkinson’s disease risk assessment and prognosis.

AI-PROGNOSIS receives funding from the European Union under Grant Agreement No. 101080581.
✔️ We wrapped up the second day of the @aiprognosis.bsky.social 6th Plenary Meeting with productive discussions and clear priorities for the months ahead.

A warm thank-you to The Cyprus Institute of Neurology & Genetics for hosting us in Nicosia 😊

#ParkinsonsDisease #HorizonEurope
November 27, 2025 at 3:04 PM
💡Today we opened the @aiprognosis.bsky.social 6th Plenary Meeting, hosted by the Cyprus Institute of Neurology & Genetics (CING) in Nicosia.
The consortium reviewed project progress and shared updates on current research activities.
Looking forward to tomorrow’s sessions.
#Parkinsons
November 26, 2025 at 2:16 PM
The @aiprognosis.bsky.social team is heading to Nicosia for our 6th Plenary Meeting on 26–27 November.
We’ll review progress, share updates, and plan the next steps for advancing AI tools in Parkinson’s care.
Follow our work 👉 ai-prognosis.eu

#DigitalHealth #ParkinsonsDisease #HorizonEurope
November 20, 2025 at 7:24 AM
📄 New on the @aiprognosis.bsky.social Learning Hub:
Predicting Parkinson’s Progression with AI
The article outlines current research, key challenges, and why prognostic information must be shared with care.
🔗 www.ai-prognosis.eu/learning-hub...

#ParkinsonsDisease #AI
November 19, 2025 at 10:37 AM
@aiprognosis.bsky.social at DGN 2025
Dr. Arnfin Bergmann and Niloofar Tavakoli (NeuroTransData) presented the project to clinicians, highlighting its clinical relevance. The project was also shared during an NTD Shareholders Meeting to support further clinical engagement.
#Parkinsons #HorizonEurope
November 18, 2025 at 8:35 AM
📌 Webinar (in Swedish): Parkinson’s Disease & Artificial Intelligence. What does AI really mean for people with Parkinson’s and their families?
🗓️ 25 Nov 2025 | 17:00–18:30 CET
Sara Riggare & Therese Scott Duncan, Uppsala University
👉 Register: shorturl.at/nSMP2

#Parkinsons
November 11, 2025 at 7:46 AM
💡 #HealthCom2025 – Workshop Chairing
Stelios Hadjidimitriou (AUTH) co-chaired the workshop “AI-enabled Digital Health Tools for Non-Communicable Diseases”, co-organised with @iprolepsis.bsky.social .
Featured research on #Parkinson’s, psoriatic arthritis, MS & post-stroke rehab.

#HorizonEU
November 4, 2025 at 7:35 AM
At #HealthCom2025 in Abu Dhabi, the AI-PROGNOSIS team joined the panel “Digital Bridges for Better Health: AI Innovation from Europe to MENA”
Discussion covered AI integration, patient engagement, and cross-regional collaboration in digital health.

#DigitalHealth #AIinHealthcare #PatientEngagement
November 3, 2025 at 7:23 AM
The 8th @aiprognosis.bsky.social Newsletter is out.
Explore our latest updates on:
• Ongoing survey on AI in Parkinson’s care
• New Learning Hub articles on Parkinson’s & AI
• Highlights from IEEE HealthCom 2025 and other events

Read more www.ai-prognosis.eu/_files/ugd/9...

#ParkinsonsDisease
October 31, 2025 at 9:09 AM
💡 #HealthCom2025 Highlight 2
The paper “A Deep Learning Approach for Parkinsonian Tremor Assessment Using Wearables” by Theocharis Chatzis and team at CERTH received the Best Workshop Paper Award 🏆

#ParkinsonsDisease #DigitalBiomarkers #Wearables #DeepLearning
October 30, 2025 at 9:44 AM
At IEEE #HealthCom2025, Apostolos Moustaklis (AUTH) presented “On capturing effects of medication change in #Parkinson’s disease with wrist accelerometry-based digital biomarkers”. Using Verily Study Watch data (PPMI), the study showed wrist metrics can reflect effects of higher medication doses.
October 29, 2025 at 11:54 AM
Preliminary results from the @aiprognosis.bsky.social survey show symptom tracking as the most valued AI feature.
PwP highlight motor symptoms, professionals non-motor ones.

Do these findings reflect your experience?
👉Take the survey and share your opinion www.ai-prognosis.eu/survey

#parkinsons
October 28, 2025 at 8:52 AM
AI tools are being explored to help detect Parkinson’s disease earlier and support clinicians in diagnosis.
New article now on the @aiprognosis.bsky.social
Learning Hub: Using AI to Strengthen Parkinson’s Diagnosis
👉 Read here: ai-prognosis.eu/learning-hub...

#Parkinsonsdisease #HealthTech
Using AI to strengthen Parkinson’s diagnosis
Diagnosing Parkinson’s disease (PD) can be challenging, especially in the early stages. The early symptoms can be subtle or overlap with other disorders, and PD is defined clinically, so there is no l...
www.ai-prognosis.eu
October 20, 2025 at 10:42 AM
@aiprognosis.bsky.social joins #IEEEHealthCom 2025 in Abu Dhabi. Project team members will join Panel I: Digital Bridges for Better Health – AI Innovation from Europe to MENA.
🔗 Detailed programme: healthcom2025.ieee-healthcom.org/program/detailed-program

#DigitalHealth #HealthTech
October 16, 2025 at 7:17 AM
@aiprognosis.bsky.social will join #IEEEHealthCom 2025 in Abu Dhabi! The team will present two papers on how #AI and #wearables can support monitoring and management of #ParkinsonsDisease.
🗓️ 21 Oct 2025
🔗 healthcom2025.ieee-healthcom.org/program/detailed-program

#DigitalHealth #HorizonEurope
October 15, 2025 at 10:22 AM
💡 Tracking symptoms is important in #Parkinsons care – but tracking alone is not enough.
In @aiprognosis.bsky.social, participants stressed that data matters only when it leads to actionable insights that support daily life and clinical care.
🔗 bit.ly/3J5qlfx

#DigitalHealth
October 14, 2025 at 9:57 AM
Help improve #Parkinsons care. Share your opinion in the
@aiprognosis.bsky.social survey on using AI to support Parkinson’s care.
👥 Adults 18+, people with Parkinson’s, caregivers & healthcare professionals welcome.
🌍 English, French, German, Spanish

Take part: ai-prognosis.eu/survey
October 9, 2025 at 7:34 AM
Life with Parkinson’s is more than managing symptoms. It’s about selfcare, support, and partnership.
New article now on the @aiprognosis.bsky.social Learning Hub: Living with Parkinson’s Disease

👉 Read here: www.ai-prognosis.eu/articles

#Parkinsons #LivingWithParkinsons
October 2, 2025 at 7:54 AM
@aiprognosis.bsky.social partner NeuroTransData attended ECTRIMS 2025 – the leading MS research congress.

A great occasion to network and raise visibility for the AI-PROGNOSIS project in the wider neurodegeneration and digital health community.

#ECTRIMS2025 #ResearchCollaboration
September 26, 2025 at 10:06 AM
📚 Getting a #Parkinsons diagnosis is often a long journey. Early, subtle signs may appear years before motor symptoms, but without a single test, doctors must rely on clinical evaluation.

Read the full article on the @aiprognosis.bsky.social Learning Hub:
👉 www.ai-prognosis.eu/learning-hub...
September 18, 2025 at 6:35 AM
New open-access publication from @aiprognosis.bsky.social
in @jmirpub.bsky.social: Stakeholder perspectives on #AI for #ParkinsonsDisease highlight the need for trust, transparency, fairness & human oversight.

👉 jmir.org/2025/1/e73710

#DigitalHealth #EthicalAI
Stakeholder Perspectives on Trustworthy AI for Parkinson Disease Management Using a Cocreation Approach: Qualitative Exploratory Study
Background: Parkinson disease (PD) is the fastest-growing neurodegenerative disorder in the world, with prevalence expected to exceed 12 million by 2040, which poses significant health care and societ...
jmir.org
September 16, 2025 at 6:33 AM
💡 AI can support better #Parkinson’s care – but what do patients & healthcare professionals think?
In @aiprognosis.bsky.social, they see opportunities in earlier diagnosis & personalised care, but raise concerns about trust, privacy & oversight.

👉 Read more: www.ai-prognosis.eu/news/trust-a...
September 10, 2025 at 5:45 AM
💡 AI in healthcare isn’t just about algorithms – it’s about people. In @aiprognosis.bsky.social, people with Parkinson’s, caregivers & healthcare professionals help co-create digital tools built on trust, inclusivity & real needs.
👉 www.ai-prognosis.eu/news/shaping...

#Parkinsons #AI #CoCreation
September 3, 2025 at 7:04 AM
💡What does it take to launch a clinical study across multiple sites? @aiprognosis.bsky.social set up consistent recruitment protocols, secured regulatory approvals, and tackled early operational challenges during the launch of its first clinical study (dBM-DEV).
🔗 zenodo.org/records/1554...
August 26, 2025 at 9:16 AM